Within-participant micro-randomization for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Michigan, Ann Arbor, MI
Depression+3 More
Intern Health Study behavioral change mobile notification - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The aim of this trial is to evaluate the efficacy of an intervention (delivered through a smartphone) for improving the mood, physical activity, and sleep of medical interns.

Eligible Conditions

  • Depression
  • Sleep
  • Physical Activities
  • Mood

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: Daily, through study completion at the end of intern year (1 year)

Year 1
Average daily mood
Average daily step count
Average nightly sleep duration
Year 1
Patient Health Questionnaire-9 (PHQ-9)

Trial Safety

Trial Design

1 Treatment Group

Within-participant micro-randomization
1 of 1
Experimental Treatment

1150 Total Participants · 1 Treatment Group

Primary Treatment: Within-participant micro-randomization · No Placebo Group · N/A

Within-participant micro-randomization
Behavioral
Experimental Group · 1 Intervention: Intern Health Study behavioral change mobile notification · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intern Health Study behavioral change mobile notification
2018
N/A
~2140

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: daily, through study completion at the end of intern year (1 year)

Trial Background

Prof. Srijan Sen, Research Professor
Principal Investigator
University of Michigan
Closest Location: University of Michigan · Ann Arbor, MI
Photo of university of michigan comprehensive cancer center  1Photo of university of michigan comprehensive cancer center  2Photo of university of michigan comprehensive cancer center  3
2022First Recorded Clinical Trial
37 TrialsResearching Depression
1003 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You use an iPhone or Android phone.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.